Active

Do cancer cells work “collectively” to survive?

Cancer types:

Melanoma

Project period:

Research institute:

Radboud University Medical Center

Award amount:

£199,969

Location:

Netherlands

Researcher Professor Peter Friedl

Professor Peter Friedl and his team are studying how a shared cell survival system could be behind both cancer cell spread and treatment resistance. This could reveal brand new ways to stop cancer in its tracks.

Hope for the future

Once melanoma and other cancers have spread (metastasised), they can no longer be treated with surgery – instead, a system-wide approach to treatment is needed. Unfortunately, metastatic cancers are difficult to treat, and even the latest drugs are only able to extend a patient’s life by a few months. 

Professor Peter Friedl believes that it may be possible to target both the spread of cancer cells and how they resist treatment at the same time, and that this could be a promising path to new treatments. Professor Friedl and other cancer researchers have started to uncover how cancer cells may communicate, possibly working “collectively”, to spread around the body and avoid the effects of treatments. Uncovering this knowledge could help find ways to make treatments like chemotherapy more effective for more cancer patients. 

The science

Cancer cells are often thought about as “lonely riders”, says Professor Friedl, but in fact they may be able to form a kind of multi-cell ecosystem that benefits the cells by helping them spread and avoid being killed. These two survival systems, cancer spread and treatment resistance, are usually studied independently – as separate survival methods performed in different ways. 

If successful, this project could be the first in the world to bridge the gap between cancer metastasis and treatment resistance, and show that communication between cells that helps them act “collectively” is behind both behaviours. By uncovering how cells communicate to do this, Professor Friedl believes they could reveal brand new ways to target cancer cells – disrupt the systems cancer cells use to act “collectively”, and you could both slow their spread and expose them to the effects of treatments. 

Related projects

Professor Sophia Karagiannis Team

Active United Kingdom

Melanoma

How can we help treatments work for more melanoma patients?

Immunotherapy currently does not work for half of all melanoma patients. This project hopes that understanding allergic reactions could lead to new solutions.

Researcher: Professor Sophia Karagiannis

Atchoo! Can understanding allergic reactions lead to new cancer treatments?

Active United Kingdom

Melanoma

Why do some melanoma patients stop responding to therapy?

Researchers hope to find new drug targets that could make immunotherapies more effective, making them a better option for more people with advanced melanoma.

Researcher: Dr Adam Hurlstone

Reversing resistance to immune checkpoint inhibitors

Active United Kingdom

Melanoma

How does melanoma adapt to spread and seed new tumours?

Cancers is easier to treat when caught early so this project hopes to reveal new treatments that could stop melanoma spreading, helping survival rates.

Researcher: Professor Victoria Sanz-Moreno

Understanding how melanoma adapts to spread and seed new tumours
Share this page